europcr 22: forward pro study shows no durability issues after 3 years
Published 3 months ago • 17 plays • Length 4:47Download video MP4
Download video MP3
Similar videos
-
4:21
europcr 22: decision qfr shows increased practicability and shorter procedure time for revasc
-
8:14
europcr 2019: forward pro study - prof eberhard grube
-
11:29
impact of bvf on valve durability/integrity - #tct2022
-
3:29
europcr 22: aqva study shows superiority in qfr-based virtual pci arm
-
5:56
europcr 22: master-dapt sub-analysis shows consistent results in complex pci patients
-
2:16
europcr 22: scb with micro-reservoir technology in coronary lesions
-
1:21:39
the right valve choice for tavi patient longevity and durability - europcr 2022
-
10:12
artificial intelligence (ai) in interventional cardiology - europcr 2024
-
40:31
the future of interventional cardiology imaging - europcr 2024
-
27:15
view from the thoraxcenter: europcr 22 late-breaking science wrap-up
-
5:31
sensor-guided tavi using the savvywire pre-shaped pressure guidewire - #europcr 2024
-
3:35
europcr 22: cruz-hbr indicates use of supraflux™ cruz stent is favourable
-
48:48
the complexity in treatment of patients in shock - europcr 2024
-
1:23
what makes europcr unique?
-
3:17
europcr 22: eastbourne registry indicates satefy of sirolimus-coated balloon